Search results
Showing: 10 of 145
Drug Tariff Part XIV
Detailed information on Part XIV of the Drug Tariff.
Part XIVB: arrangements for contractors concerning prescription pricing errors
This information applies to pharmacy contractors in England only.
From 1 April 2012
From April 2012, a…
Part IX Guidance to manufacturers and suppliers of medical devices
Following the publication by the European Commission of a correction to the 13 May 2016 list of harmonized standards under the European Directive 98/79/EC of the European Parliament and of the Council on in vitro diagnostic (IVD) medical devices,…
Local authorities
A Local Authority commissioning a public health service must determine whether the service will provide medicines and appliances to patients using FP10 prescriptions.
The Local Authority will be responsible for the cost of FP10 prescriptions issued…
Retrospective changes for July 2019
The Department of Health and Social Care and the Welsh Government have retrospectively determined that from July 2019:
Melatonin 1mg/ml oral solution sugar free (150ml) – is added to Category C based on Colonis Pharma, and
Melatonin 5mg/5ml oral…
Brimonidine and duloxetine reimbursement prices
The Department of Health and Social Care and the National Assembly of Wales have re-determined that the reimbursement prices for the following items will be:
brimonidine 0.2% eye drops (5ml) - £2.11 (instead of £1.68)
duloxetine 60mg gastro-…
Help your patients understand how their prescription information is used and protected
A new data privacy law will be introduced in the UK in May 2018. As a result, we’ve published a new privacy notice to make it easier for patients to find out how the NHS Business Services Authority uses and protects their prescription information.…
Electronic repeat dispensing (eRD)
Jump to:
What is eRD?
First introduced in 2009, Electronic Repeat Dispensing (eRD) is a non-compulsory method of dispensing prescriptions electronically. It means that patients who regularly get the same medicine do not need to visit their GP…
Retrospective Mebeverine 50mg/5ml price adjustment in NHS England and Wales from December 2022 to February 2023
This is an announcement on behalf of the Department of Health and Social Care.
The Department of Health and Social Care can confirm that the following product will have a redetermination due to late notification of a price increase, this will apply…
Drug Tariff update – Omeprazole oral suspension
This is an announcement on behalf of the Department of Health and Social Care
The Department of Health and Social Care and the National Assembly of Wales have retrospectively determined from September 2023:
the addition of Omeprazole 1mg/ml…
Drug Reimbursement - Riluzole and Rilutek
The Department of Health and Social Care (DHSC) have clarified that for Riluzole 50mg tablets (Part VIIIA Category A) and Rilutek 50mg tablets, contractors will be reimbursed the following for NHS prescriptions dispensed in January 2024…